Lassa Fever Therapeutic and Overview Pipeline Review H2


Lassa Fever Treatment Pipeline Review H2 2016

PUNE, INDIA, November 15, 2016 / — The report provides comprehensive information on the therapeutics under development for Lassa Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Lassa Fever and features dormant and discontinued projects.

Get Sample Report @

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

– The report provides a snapshot of the global therapeutic landscape of Lassa Fever
– The report reviews pipeline therapeutics for Lassa Fever by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Lassa Fever therapeutics and enlists all their major and minor projects
– The report assesses Lassa Fever therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Lassa Fever

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Lassa Fever
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Lassa Fever pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Lassa Fever Overview 7
Therapeutics Development 8
Pipeline Products for Lassa Fever – Overview 8
Pipeline Products for Lassa Fever – Comparative Analysis 9
Lassa Fever – Therapeutics under Development by Companies 10
Lassa Fever – Therapeutics under Investigation by Universities/Institutes 11
Lassa Fever – Pipeline Products Glance 12
Early Stage Products 12
Lassa Fever – Products under Development by Companies 13
Lassa Fever – Products under Investigation by Universities/Institutes 14
Lassa Fever – Companies Involved in Therapeutics Development 15
Arno Therapeutics, Inc. 15
Celgene Corporation 16
Etubics Corporation 17
Kineta, Inc. 18
Profectus BioSciences, Inc. 19
SIGA Technologies, Inc. 20
Lassa Fever – Therapeutics Assessment 21
Assessment by Monotherapy Products 21
Assessment by Target 22
Assessment by Mechanism of Action 24
Assessment by Route of Administration 26
Assessment by Molecule Type 28
Drug Profiles 30
AR-12 – Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
CC-11050 – Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
DEF-201 – Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
FBH-003 – Drug Profile 36

Access Report @

Get in touch:

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR